The potential therapeutic effects of Dasatinib in AD stem from its ability to impinge on multiple cellular mechanisms, which share the involvement of Src tyrosine kinases, such as the oxidation of integrin-α5-KCNB1 complexes [64,98]. The gene discussed is IGKV2D-26; the disease is Alzheimer disease.